ArticleBMC medical imaging2025
MRI findings for the pretreatment diagnosis of small Meckel's cave tumors: comparison of meningiomas and schwannomas.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBoth meningiomas and schwannomas are the most common Meckel's cave (MC) tumors in terms of distinct imaging features. When they are small, they may present with similar imaging characteristics that make their diagnosis difficult. The aim of this study was to diagnose small meningiomas and schwannomas of the MC on the basis of their clinical and MRI findings.
methodsThe clinical data of 33 patients who were diagnosed with small MC tumors (SMCTs) (17 schwannomas, 16 meningiomas) between August 2002 and August 2023 were retrospectively evaluated. SMCTs were defined as MC tumors that were less than 3 cm in size. We analyzed their clinical and MRI findings, including demographic features, lesion morphologies and changes in adjacent structures.
resultsThe rate of subtotal resection of meningiomas less than 3 cm in size was significantly lower than that of schwannomas less than 3 cm in size (43.8% vs. 100%, p = 0.032). The MRI features of meningiomas and schwannomas were as follows: 1) a prominent dura tail sign (8/16 [50%] vs. 0/17 [0%], p < 0.001); 2) few cystic components (0/16 [0%] vs. 9/17 [52.94%], p < 0.001); 3) lower minimum ADC (ADCmin) values (820.575 ± 302.545 [86.1-1144.4] vs. 1372.424 ± 561.337 [355.7-2616.6], p < 0.001); and 4) minimal ipsilateral masticatory muscle atrophy (-6.71% ± 22.43% [-85.71% ~ 13.79%] vs. 11.24% ± 11.98% [-14% ~ 38%], p < 0.001). Very small MC tumors (VSMCTs) were ≤ 2 cm in size, and the subgroup analysis of very small meningiomas and schwannomas revealed no differences in terms of ipsilateral masticatory muscle atrophy (p = 0.078), prominence of the dural tail (p = 0.236), or the presence of cystic components (p = 0. 364). However, the ADCmin values were significantly lower for very small meningiomas than for very small schwannomas (p = 0.009).
conclusionMRI features such as a prominent dural tail appearance, the presence of fewer cystic components, and less masticatory muscle atrophy may aid in differentiating meningiomas from schwannomas less than 3 cm in size. The ADC and DWI parameters provided additional critical insights, particularly for VSMCTs, thus facilitating preoperative diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.